Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Varonis Systems Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Varonis Systems wird ein jährliches Gewinn- und Umsatzwachstum von 19.5% bzw. 11% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 32.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.1% betragen.
Wichtige Informationen
19.9%
Wachstumsrate der Gewinne
32.8%
EPS-Wachstumsrate
| Software Gewinnwachstum | 15.7% |
| Wachstumsrate der Einnahmen | 11.0% |
| Zukünftige Eigenkapitalrendite | 9.1% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 05 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Calculating The Fair Value Of Varonis Systems, Inc. (NASDAQ:VRNS)
May 31
Varonis Systems: SaaS Transition Going Well
May 29When Should You Buy Varonis Systems, Inc. (NASDAQ:VRNS)?
Apr 24Investor Optimism Abounds Varonis Systems, Inc. (NASDAQ:VRNS) But Growth Is Lacking
Apr 06Health Check: How Prudently Does Varonis Systems (NASDAQ:VRNS) Use Debt?
Mar 19Varonis Systems: Solid Outlook For The Business
Feb 19Is Varonis Systems, Inc. (NASDAQ:VRNS) Trading At A 26% Discount?
Feb 09Varonis: Still Strong Demand Due To Secular Growth Drivers
Feb 08Is Now The Time To Look At Buying Varonis Systems, Inc. (NASDAQ:VRNS)?
Jan 22Varonis Systems, Inc.'s (NASDAQ:VRNS) Business Is Trailing The Industry But Its Shares Aren't
Jan 04Does Varonis Systems (NASDAQ:VRNS) Have A Healthy Balance Sheet?
Dec 17An Intrinsic Calculation For Varonis Systems, Inc. (NASDAQ:VRNS) Suggests It's 40% Undervalued
Oct 27Is Varonis Systems, Inc. (NASDAQ:VRNS) Potentially Undervalued?
Oct 09Is Varonis Systems (NASDAQ:VRNS) Weighed On By Its Debt Load?
Sep 18What Varonis Systems, Inc.'s (NASDAQ:VRNS) P/S Is Not Telling You
Aug 17Is There An Opportunity With Varonis Systems, Inc.'s (NASDAQ:VRNS) 34% Undervaluation?
Jul 05At US$25.65, Is Varonis Systems, Inc. (NASDAQ:VRNS) Worth Looking At Closely?
May 29Is Varonis Systems (NASDAQ:VRNS) Weighed On By Its Debt Load?
May 11Estimating The Intrinsic Value Of Varonis Systems, Inc. (NASDAQ:VRNS)
Mar 28Health Check: How Prudently Does Varonis Systems (NASDAQ:VRNS) Use Debt?
Feb 06A Look At The Fair Value Of Varonis Systems, Inc. (NASDAQ:VRNS)
Dec 24When Should You Buy Varonis Systems, Inc. (NASDAQ:VRNS)?
Dec 02Revenue Downgrade: Here's What Analysts Forecast For Varonis Systems, Inc. (NASDAQ:VRNS)
Nov 06Does Varonis Systems (NASDAQ:VRNS) Have A Healthy Balance Sheet?
Oct 16Varonis Systems Grows Revenue But Operating Losses And Risks Remain High
Oct 03Varonis: Value, Growth, And Huge Data Security Tailwinds
Sep 18Varonis Non-GAAP EPS of $0.00 beats by $0.01, revenue of $111.45M beats by $0.19M, raises FY22 EPS guidance
Aug 01Wolfe Research downgrades Varonis Systems ahead of Q2 earnings, cites slowing demand
Jul 25Is Varonis Systems (NASDAQ:VRNS) Weighed On By Its Debt Load?
Jul 13Varonis Systems' price target cut at Barclays as stock slides to 52-week low
Jul 12Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 705 | -80 | 137 | 150 | 7 |
| 12/31/2025 | 612 | -126 | 92 | 105 | 19 |
| 12/31/2024 | 542 | -122 | 73 | 81 | 19 |
| 3/31/2024 | 506 | -103 | 75 | 79 | N/A |
| 12/31/2023 | 499 | -101 | 54 | 59 | N/A |
| 9/30/2023 | 488 | -111 | 46 | 52 | N/A |
| 6/30/2023 | 489 | -116 | 37 | 44 | N/A |
| 3/31/2023 | 485 | -114 | 15 | 24 | N/A |
| 12/31/2022 | 474 | -125 | 0 | 12 | N/A |
| 9/30/2022 | 458 | -139 | -5 | 9 | N/A |
| 6/30/2022 | 435 | -133 | -8 | 6 | N/A |
| 3/31/2022 | 412 | -130 | -2 | 11 | N/A |
| 12/31/2021 | 390 | -117 | -3 | 7 | N/A |
| 9/30/2021 | 359 | -111 | 7 | 14 | N/A |
| 6/30/2021 | 335 | -107 | 8 | 16 | N/A |
| 3/31/2021 | 313 | -98 | 2 | 11 | N/A |
| 12/31/2020 | 293 | -94 | -16 | -6 | N/A |
| 9/30/2020 | 270 | -90 | -32 | -14 | N/A |
| 6/30/2020 | 259 | -87 | -44 | -24 | N/A |
| 3/31/2020 | 252 | -88 | -44 | -21 | N/A |
| 12/31/2019 | 254 | -79 | -36 | -11 | N/A |
| 9/30/2019 | 269 | -58 | -24 | -3 | N/A |
| 6/30/2019 | 271 | -48 | -11 | 6 | N/A |
| 3/31/2019 | 273 | -36 | 7 | 20 | N/A |
| 12/31/2018 | 270 | -29 | 14 | 24 | N/A |
| 9/30/2018 | 256 | -28 | 17 | 22 | N/A |
| 6/30/2018 | 242 | -24 | 24 | 29 | N/A |
| 3/31/2018 | 229 | -17 | 21 | 25 | N/A |
| 12/31/2017 | 215 | -14 | N/A | 16 | N/A |
| 9/30/2017 | 197 | -17 | N/A | 14 | N/A |
| 6/30/2017 | 184 | -18 | N/A | 12 | N/A |
| 3/31/2017 | 174 | -19 | N/A | 10 | N/A |
| 12/31/2016 | 166 | -14 | N/A | 7 | N/A |
| 9/30/2016 | 154 | -19 | N/A | 6 | N/A |
| 6/30/2016 | 144 | -19 | N/A | 5 | N/A |
| 3/31/2016 | 135 | -19 | N/A | 1 | N/A |
| 12/31/2015 | 127 | -21 | N/A | -3 | N/A |
| 9/30/2015 | 117 | -24 | N/A | -7 | N/A |
| 6/30/2015 | 111 | -26 | N/A | -12 | N/A |
| 3/31/2015 | 107 | -24 | N/A | -10 | N/A |
| 12/31/2014 | 101 | -19 | N/A | -7 | N/A |
| 9/30/2014 | 93 | -18 | N/A | -5 | N/A |
| 6/30/2014 | 86 | -14 | N/A | -1 | N/A |
| 3/31/2014 | 79 | -11 | N/A | 1 | N/A |
| 12/31/2013 | 75 | -7 | N/A | 0 | N/A |
| 9/30/2013 | 67 | -7 | N/A | 2 | N/A |
| 6/30/2013 | 62 | -4 | N/A | 2 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: VRNS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.
Ertrag vs. Markt: VRNS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.
Hohe Wachstumserträge: VRNS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.
Einnahmen vs. Markt: VRNSDie Einnahmen des Unternehmens (11% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.4% pro Jahr).
Hohe Wachstumseinnahmen: VRNSDie Einnahmen des Unternehmens (11% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: VRNSDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.1 %).